Hematology
1952, publication by James W. Farquhar and Albert Claireaux in the United Kingdom
Hemophagocytic lymphohistiocytosis, a severe condition involving dysregulated activation of immune cells that consume blood cells, was not recognized as a distinct clinical entity until the twentieth century, when pathologists examining tissue specimens began identifying a characteristic pattern of immune cell engulfment. For much of medical history, the constellation of findings it produced was attributed to a variety of other conditions including infections, malignancies, and obscure febrile illnesses. The history of its recognition is closely tied to the development of hematopathology and immunology as formal disciplines.
Historical Narrative
Because hemophagocytic lymphohistiocytosis was not identified as a distinct disease until the modern era, its earliest historical footprint exists not as a named condition but as a cluster of baffling, often fatal clinical presentations recorded under various other diagnoses. Nineteenth-century physicians encountering patients with severe fever, enlarged spleens, and rapidly declining blood counts typically attributed such cases to typhoid fever, septicemia, miliary tuberculosis, or unexplained malignancy. Postmortem examinations occasionally revealed unusual tissue findings — immune cells stuffed with engulfed red blood cells and other blood elements — but these findings were recorded as curiosities rather than as evidence of a unified pathological process.
The formal identification of the hemophagocytic phenomenon is credited to Scottish pathologist James W. Farquhar and his colleague Albert Claireaux, who in 1952 published descriptions of a series of familial cases in young children in which postmortem tissue examination revealed a striking pattern of histiocytes actively engulfing red blood cells, white blood cells, and platelets throughout the body's lymphoid organs. Farquhar and Claireaux named this familial hemophagocytic reticulosis, distinguishing it from leukemia and other blood disorders by its characteristic pathological appearance and its tendency to recur within families, suggesting a hereditary basis.
This 1952 publication is generally considered the founding document of hemophagocytic lymphohistiocytosis as a recognized clinical and pathological entity. The cases Farquhar and Claireaux described were uniformly fatal in the children they examined, and the condition was understood at that time as an almost invariably lethal disorder of early childhood with no known effective intervention.
Through the 1950s and 1960s, pathologists in Europe and North America began identifying similar patterns in tissue specimens from patients of various ages and backgrounds, and a slow accumulation of case reports established that the hemophagocytic process could arise in multiple settings — sometimes in children with apparent hereditary predisposition and sometimes in individuals with underlying infections or malignancies. The distinction between these two broad scenarios — hereditary and acquired — became a recurring preoccupation in the medical literature of this era.
Jan Rappaport and colleagues contributed to refining pathological classification during the 1960s and 1970s, as hematopathology developed more sophisticated methods for examining lymphoid and bone marrow tissue. The application of bone marrow biopsy as a diagnostic procedure proved important, as hemophagocytic activity could sometimes be demonstrated in marrow specimens obtained from living patients rather than exclusively at autopsy.
The 1970s and 1980s saw growing international attention to the condition, with Japanese and European investigators publishing substantial case series and attempting to establish consistent diagnostic criteria. Researchers at the Histiocyte Society, founded in 1985, played a central organizing role in standardizing terminology, merging what had been described under multiple names — familial hemophagocytic reticulosis, virus-associated hemophagocytic syndrome, and others — into the unified designation of hemophagocytic lymphohistiocytosis. This consolidation allowed investigators to compare findings across institutions and countries for the first time in a systematic way, marking a new phase in the condition's medical history.
Key Historical Figures
Historical narrative only — this page describes how Hemophagocytic lymphohistiocytosis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.